Summary
The effect of clofibrate treatment (1.5 g/day for four weeks) on triglycerides, cholesterol and phospholipids in very low density lipoproteins (VLDL), low density lipoproteins (LDL) and high density lipoproteins (HDL) was investigated in 12 patients with type IV hyperlipoproteinaemia. The decrease of serum triglycerides was due to the reduction of VLDL-triglycerides. Furthermore, LDL-hypertriglyceridemia was normalised by clofibrate. — There existed a significant decrease of VLDL- und HDL-cholesterol as well as of VLDL-phospholipids.
The changes in LDL-cholesterol and LDL-phospholipids by clofibrate depended on their initial concentrations which were negatively correlated to the serum triglycerides before treatment. — The normalisation of lipid concentrations in VLDL and LDI could be explained by a stimulated delipidation of the apo B-lipoproteins.
Zusammenfassung
Der Einfluß einer vierwöchigen Clofibratbehandlung auf den Triglycerid-, Cholesterin-und Phospholipidgehalt von Very Low Density Lipoproteins (VLDL), Low Density Lipoproteins (LDL) und High Density Lipoproteins (HDL) wurde bei 12 Patienten mit primärer Typ IV-Hyperlipoproteinämie untersucht. Die Senkung der Serumtriglyceride war durch einen Abfall der VLDL-Triglyceride bedingt. Darüber hinaus kam es zu einer Normalisierung der zum Teil nachweisbaren LDL-Hypertriglyceridämie. — Die Cholesterinkonzentration nahm in den VLDL und HDL, der Phospholipidgehalt nur in den VLDL signifikant ab. In den LDL änderten sich diese beiden Lipide in Abhängigkeit von ihren Ausgangswerten, die negativ mit den Serumtriglyceridkonzentrationen korrelierten. Die Normalisierung von VLDL- und LDL-Lipiden könnte mit einer beschleunigten Delipidation der Apo-B-Lipoproteine erklärt werden.
Similar content being viewed by others
Literatur
Brown, H.B., Lewis, L.A., Page, I.H.: Effects of clofibrate and a fat-modified diet on serum lipids. Clin. Pharmacol. Ther.17, 171 (1975)
Burstein, M., Scholnick, H.R., Morfin, R.: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res.11, 583 (1970)
Carlson, L.A., Olsson, A.G., Orö, L., Rössner, St., Walldius, G.: Effects of hypolipidemic regimes on serum lipoproteins. Proc. of the Third Intern. Symp. on Atherosclerosis, Berlin 1973. In: Atherosclerosis III, ed.: G. Schettler, p. 768. Berlin-Heidelberg-New York: Springer 1974
Documenta Geigy, Wissenschaftliche Tabellen, 1960
Eggstein, M., Kreutz, F.H.: Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. Klin. Wschr.44, 262 (1966)
Eisenberg, S.: Lipoprotein metabolism and hyperlipemia. Atherosclerosis Reviews1, ed. R. Paoletti, A.M. Gotto, S. 23. New York: Raven Press 1976
Fiske, C.H., Subbarow, Y.: The colorimetric determination of phosphorus. J. biol. Chem.66, No. 2, 375 (1925)
Folch, J., Lees, M., Sloane Stanley, G.H.: A simple method for the isolation and purification of total lipids from animal tissues. J. biol. Chem.226, 497 (1957)
Havel, R.J., Eder, H.A., Bragdon, J.H.: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. clin. Invest34, 1345 (1955)
Havel, R.J., Kane, J.P., Balasse, E.O., Segel, N., Basso, L.V.: Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J. clin. Invest.49, 2017 (1970)
Levy, R.I., Fredrickson, D.S., Shulman, R., Bilheimer, D.W., Breslow, J.L., Stone, N.J., Lux, S.E., Sloan, H.R., Krauss, R.M., Herbert, P.N.: Dietary and drug treatment of primary hyperlipoproteinemia. Ann. intern. Med.77, 267 (1972)
Miller, G.J., Miller, N.E.: Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1975I, 16
Morganroth, J., Levy, R.I.: The diagnosis and management of the hyperlipoproteinemias. In: Drug in cardiology, ed.: E. Donoso, p. 127. New York: Medical Book Corp 1975
Noble, R.P.: Electrophoretic separation of plasma lipoproteins in agarosegel. J. Lipid Res.9, 693 (1968)
Olsson, A.G., Orö, L., Rössner, S.: Dose-response effect of single and combined clofibrate (Atromid®) and nicitrol (Perycit®) treatment on serum lipids and lipoproteins in type II hyperlipoproteinemia.
Quarfordt, S.H., Frank, A., Shames, D.M., Berman, M., Steinberg, D.: Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets. J. clin. Invest.49, 2281 (1970)
Radding, Ch.M., Steinberg, D.: Studies on the synthesis and secretion of serum lipoproteins by rat liver slices. J. clin. Invest.39, 1560 (1960)
Reaven, G.M., Lerner, R.L., Stern, M.P.: Role of insulin in endogenous hypertriglyceridemia. J. clin. Invest.46, 1756 (1967)
Röschlau, P., Bernt, E., Gruber, W.: Enzymatische Bestimmung des Gesamtcholesterins im Serum. Z. klin. Chem.12, 403 (1974)
Sailer, S., Bolzano, K., Sandhofer, F.: Triglyceridspiegel und Insulinkonzentration im Plasma nach oraler Glukosegabe bei Patienten mit primärer kohlenhydratinduzierter Hypertriglyceridämie. Schweiz. med. Wschr.98, 1512 (1968)
Seidel, D., Wieland, H., Ruppert, C.: Improved techniques for assessment of plasma lipoprotein patterns. I. Precipitation in gels after electrophoresis with polyanionic compounds. Clin. Chem.19/7, 737 (1973)
Shames, D.M., Frank, A., Steinberg, D., Berman, M.: Transport of plasma free fatty acids and triglycerides in man: a theoretical analysis. J. clin. Invest.49, 2298 (1970)
Strisower, E.H., Adamson, G., Strisower, B.: Treatment of hyperlipidemias. Amer. J. Med.45, 488 (1968)
Vessby, B., Lithell, H., Boberg, J., Werner, J.: Effect of PASC® on serum lipoproteins when combined with lipid lowering diet and clofibrate. Artery2, 70 (1976)
Wilson, D.E., Lees, R.S.: Metabolic relationship among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. J. clin. Invest.51, 1051 (1971)
Wolfe, B.M., Kane, Y.P., Havel, R.J., Brewster, H.P.: Mechanism of the hypolipemic effect of clofibrate in postabsorptive man. J. clin. Invest.52, 2146 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weisweiler, P., Schwandt, P. Lipoproteinveränderungen unter Clofibrat bei Typ IV-Hyperlipoproteinämien. Klin Wochenschr 55, 791–794 (1977). https://doi.org/10.1007/BF01651267
Issue Date:
DOI: https://doi.org/10.1007/BF01651267